Related Experiment Videos

Electrocardiographic changes after long-term treatment with sotalol in hypertensive patients

International Journal of Clinical Pharmacology, Therapy, and Toxicology
|February 1, 1982
PubMed

Insights

Sotalol, a beta blocker, prolonged cardiac repolarization (PR and QT intervals) in hypertensive patients during rest and exercise. Heart rate was lower in sotalol-treated patients compared to diuretic-treated patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Sotalol is a beta-blocker known to prolong cardiac repolarization in animal studies.
  • Hypertension management often involves medications affecting cardiac function.
  • Long-term electrocardiographic effects of sotalol in humans require investigation.

Purpose of the Study:

  • To investigate the long-term electrocardiographic effects of sotalol in hypertensive patients.
  • To compare these effects with those of diuretics in a matched hypertensive cohort.

Main Methods:

  • Ten hypertensive patients treated with sotalol and ten matched patients treated with diuretics were enrolled.
  • Electrocardiograms (ECG) were recorded at rest and during bicycle exercise testing.
  • Analysis focused on heart rate, PR interval, QT interval, QRS width, and corrected QT (QTC) interval.

Main Results:

  • Sotalol treatment resulted in lower resting and exercise heart rates.
  • Significantly longer PR and QT intervals were observed in the sotalol group at rest and after exercise.
  • QRS widths were comparable between the sotalol and diuretic groups.
  • Corrected QT (QTC) intervals did not show significant differences between the groups.

Conclusions:

  • Sotalol prolongs cardiac repolarization, evidenced by increased PR and QT intervals in hypertensive patients.
  • These findings align with known effects of beta-blockers on cardiac electrophysiology.
  • The study provides insights into the electrocardiographic profile of sotalol in a clinical setting.

Related Concept Videos